Bulk Orders 20+ vials
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
Exclusive Products
Batch UB01 · ILS COA-2026-SOAWUF. Open “View Currently Shipping CoA” below for this batch’s laboratory report. UBT251, also known as Vistrutide, is a premium triple agonist research peptide supplied in a 10MG lyophilized vial format, designed for controlled laboratory investigations involving...
Bundle & save
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkVerified test results
Each batch is analyzed by ILS Laboratories, an independent ISO/IEC 17025 accredited lab, before release. Below is the report for lot UB01, summarized from the certificate the lab published.
This lot ships under its own published certificate. Open any certificate below, exactly as the lab released it.
Side by side
Technical specifications
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Batch UB01 · ILS COA-2026-SOAWUF. Open “View Currently Shipping CoA” below for this batch’s laboratory report. UBT251, also known as Vistrutide, is a premium triple agonist research peptide supplied in a 10MG lyophilized vial format, designed for controlled laboratory investigations involving GLP-1 receptor pathway research, GIP receptor signaling models, glucagon receptor-associated biology, incretin pathway interaction, metabolic signaling, appetite-associated pathway research, glucose-response biology, and energy-balance pathway models.
Disguised Alpha UBT251 / Vistrutide is built for researchers studying next-generation multi-receptor incretin systems. This 10MG format gives researchers a clean, clearly labeled presentation for advanced triple agonist pathway research, supported by internal QA review, professional packaging standards, and direct in-house fulfillment.
Compound: UBT251 / Vistrutide
Strength: 10MG
Format: Lyophilized peptide research vial
Research Category: Triple agonist / GLP-1 / GIP / glucagon receptor pathway research
Research Focus: GLP-1 receptor signaling, GIP receptor pathway models, glucagon receptor-associated biology, incretin receptor interaction, metabolic pathway research, appetite-associated signaling, glucose-response pathway biology, and energy-balance pathway studies.
UBT251 / Vistrutide is studied in controlled research models involving multi-receptor incretin activity, GLP-1 / GIP / glucagon pathway interaction, metabolic response systems, and receptor-linked energy-balance biology.
Studied in models involving GLP-1, GIP, and glucagon receptor pathway interaction, incretin signaling, and multi-receptor response systems.
Relevant to laboratory investigations involving metabolic signaling, glucose-response biology, appetite-associated pathways, and energy-balance systems.
Clear 10MG strength presentation in a lyophilized peptide vial format for controlled laboratory workflows and documentation clarity.
UBT251 / Vistrutide is studied in research models involving triple agonist pathway activity, including GLP-1 receptor signaling, GIP receptor signaling, and glucagon receptor-associated biology. This makes it relevant to advanced laboratory investigations involving incretin pathway interaction, metabolic signaling, glucose-response models, and receptor-linked energy-balance biology.
Research interest in UBT251 / Vistrutide centers on how multi-receptor incretin systems may influence appetite-associated pathway behavior, glucagon-linked signaling, metabolic adaptation, glucose-response biology, and downstream receptor interaction under controlled laboratory conditions.
The 10MG lyophilized research vial format provides a clean and clearly labeled presentation for researchers studying next-generation triple agonist biology and incretin receptor pathway interaction.
Advanced incretin peptide research products require more oversight than a simple compound listing. Strength clarity, vial presentation, peptide handling, storage expectations, documentation, label accuracy, packaging quality, and fulfillment handling all matter.
Disguised Alpha reviews UBT251 / Vistrutide as a complete peptide research product with attention to 10MG strength presentation, finished-vial appearance, product documentation, internal QA, labeling accuracy, and direct fulfillment accountability.
We believe researchers should be able to verify the standards we speak about. Learn more about the independent laboratories we work with below.
Disguised Alpha is built around direct accountability. Every order is processed, inspected, packaged, and shipped by our in-house team instead of being passed off to a third-party logistics warehouse.
This gives us tighter control over formulation quality, fulfillment accuracy, packaging standards, storage conditions, and customer experience. Our goal is not to be the cheapest research supplier. It is to provide professionally handled compounds with real quality oversight behind them.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.